share_log

HC Wainwright & Co. Reiterates Buy on Aurinia Pharmaceuticals, Maintains $15 Price Target

Benzinga ·  Sep 22, 2023 06:20

HC Wainwright & Co. analyst Ed Arce reiterates Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Buy and maintains $15 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment